Renaissance Technologies’s iKang Healthcare Group, Inc. KANG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-257,360
Closed -$5.27M 3676
2018
Q2
$5.27M Buy
257,360
+212,800
+478% +$4.29M 0.01% 1760
2018
Q1
$889K Buy
44,560
+20,700
+87% +$348K ﹤0.01% 2699
2017
Q4
$377K Buy
+23,860
New +$345K ﹤0.01% 2956
2017
Q3
Sell
-150,240
Closed -$1.84M 3487
2017
Q2
$1.84M Buy
150,240
+120,740
+409% +$1.75M ﹤0.01% 2301
2017
Q1
$431K Sell
29,500
-42,600
-59% -$700K ﹤0.01% 2810
2016
Q4
$1.25M Sell
72,100
-27,300
-27% -$462K ﹤0.01% 2448
2016
Q3
$1.8M Sell
99,400
-243,800
-71% -$4.48M ﹤0.01% 2254
2016
Q2
$6.29M Sell
343,200
-156,100
-31% -$3.14M 0.01% 1460
2016
Q1
$10.9M Buy
+499,300
New +$10.4M 0.02% 1081
2015
Q3
Sell
-15,200
Closed -$294K 3486
2015
Q2
$294K Sell
15,200
-17,700
-54% -$325K ﹤0.01% 2890
2015
Q1
$534K Buy
32,900
+21,800
+196% +$364K ﹤0.01% 2569
2014
Q4
$167K Buy
+11,100
New +$198K ﹤0.01% 2719

Other funds holding KANG

Renaissance Technologies's KANG Position: Q3 2018 in Review

Renaissance Technologies sold out of iKang Healthcare Group, Inc. (KANG) in Q3 2018, closing a stake of 257,360 shares — an estimated $5.27M sold.

Renaissance Technologies first reported a position in KANG in Q4 2014 and held it in 12 quarters. The position peaked at $10.9M in Q1 2016. 52 funds tracked by Wall St. Rank hold KANG as of Q3 2018.

  • Renaissance Technologies reported no remaining iKang Healthcare Group, Inc. position as of Q3 2018 after selling out during the quarter.
  • Renaissance Technologies sold 257,360 iKang Healthcare Group, Inc. shares in Q3 2018, an estimated $5.27M.
  • Renaissance Technologies first reported a position in iKang Healthcare Group, Inc. in Q4 2014 and held it in 12 quarters.
  • Renaissance Technologies's iKang Healthcare Group, Inc. position peaked at $10.9M in Q1 2016.
  • 52 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q3 2018.

Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.